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ARTICLE
The term ‘ethics’ is defined in the New Oxford 
Dictionary of English as the ‘moral principles that 
govern a person’s behaviour or the conducting of 
an activity’. Clinicians will be very familiar with 
the four principles of medical ethics in relation to 
clinical practice (Beauchamp 1979): beneficence (to 
act in the patient’s best interest), non-maleficence 
(to do no harm), autonomy (the patient’s right to 
choice in their treatment) and justice (fairness in 
the distribution of resources). ‘Research ethics’ 
refers to fundamental ethical principles which 
should be followed when carrying out scientific 
research. It is hard to believe some of the atrocities 
carried out by doctors across the world in the 
name of medical research in the 20th century (e.g. 
the wide-ranging medical experimentation in Nazi 
Germany and the Tuskegee syphilis experiments 
in the USA, reviewed in Gaw (2006)). Although 
it seems unthinkable that such crimes would or 
could occur today, it is nonetheless imperative 
that all proposed research is reviewed objectively 
according to a standard framework to ensure 
transparency and accountability, and to protect 
participants and researchers alike. 
The principles of research ethics are in 
accordance with the Declaration of Helsinki, a 
set of articles first developed in 1964 to mandate 
physicians to act ethically in the conduct of 
research on humans and thereby ‘promote and 
safeguard the health, well-being and rights of 
patients’ (World Medical Association 2013). These 
principles apply to research in any specialty, but 
mental health research may more prominently raise 
ethical issues such as capacity and consent (Saks 
2006), owing to the nature of the conditions under 
investigation. A large number of review bodies 
exist (Table 1), some of which may be particularly 
pertinent to aspects of mental health research. 
Any research involving National Health Service 
(NHS) patients in the UK requires the approval of 
an NHS research ethics committee (REC); also, 
depending on the exact nature of the research, 
local NHS management permissions, also known 
as research and development (R&D) approvals, are 
often needed. However, the process of obtaining 
these approvals is not always straightforward, 
especially for investigators unfamiliar with the 
regulatory system. It can also be time consuming, 
potentially taking many months for a new project 
to gain all the approvals needed to commence 
the research. 
In this article, we will focus on RECs and R&D 
departments and their procedures, as they are 
the most frequently encountered bodies when 
undertaking research in the NHS.
The roles of RECs and R&D departments
RECs
All research conducted in the NHS should undergo 
review by the REC. They are: 
•• part of the Health Research Authority’s (HRA) 
National Research Ethics Service (NRES) in 
England (www.hra.nhs.uk)
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SUMMARY 
When embarking on mental health research it 
is often necessary to apply for approvals from 
one or more review bodies to ensure that the 
research is ethical and that the safety and well-
being of participants are safeguarded. This can 
be complicated and time consuming, particularly 
to those unfamiliar with the process. In this article 
we describe the approvals commonly required for 
National Health Service-based research involving 
patients and endeavour to clearly explain what is 
involved at each stage. We then highlight some of 
the main considerations, including ethical aspects, 
which are particularly pertinent to conducting 
research in the field of mental health, and finish 
with general advice and considerations for future 
developments in the area.
LEARNING OBJECTIVES
•• Gain understanding of the processes involved in 
applying for approvals in NHS research
•• Gain awareness of particular issues in mental 
health research, including capacity, consent, 
stigma and confidentiality
•• Consider factors such as the time it can take to 
obtain research permissions and the importance 
of building good working relationships with the 
relevant committees from the start
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•• managed by the Health and Care Research 
Wales Ethics Service in Wales (www.
healthandcareresearch.gov.wales/gaining-
ethical-approval) (before 2015, Health and Care 
Research Wales was named the National Institute 
for Health and Social Care Research, NISCHR) 
•• supported by the Chief Scientists Office (CSO) and 
NRES in Scotland (www.nhsresearchscotland.
org.uk/226_Research+Ethics.html) 
•• supported by the Office for Research Ethics 
Committees in Northern Ireland (ORECNI) 
(www.hscbusiness.hscni.net/orecni.htm). 
These overseeing organisations broadly aim 
to promote and support high-quality ethical 
research in the NHS and maintain patient safety 
and well-being. The specific role of RECs is to 
review research proposals and give opinions on 
whether the proposed research is ethical. RECs 
are composed of members of the public as well as 
healthcare professionals with specialist knowledge 
who can help clarify particular aspects of research 
proposals. RECs are independent of research 
sponsors, funders and investigators. There are 
currently more than 80 RECs across the UK, 
and each year they review around 6000 research 
applications. On average, they give an opinion in 
less than 40 days.
R&D departments
If research is to be carried out on the premises of 
an NHS organisation, with NHS patients or with 
NHS staff, then NHS R&D approval is likely to 
be necessary. The overall purpose of NHS R&D 
departments is to support the promotion and 
delivery of research within NHS organisations, 
providing a ‘supportive and safe environment 
for research activity’ and ‘specifically support 
individual studies’ (National Institute for Social 
Care and Health Research, undated). 
Coordinated systems for NHS R&D review 
are now in place across the UK (www.hra.nhs.
uk/resources/applying-for-reviews/nhs-hsc-rd-
review), allowing one R&D application to be made 
centrally in the first instance. Each country’s 
coordinating unit is a central organisation (e.g 
the Health and Care Research Wales) which 
conducts ‘global’ checks, ensuring that all 
necessary information and documentation has 
been submitted. These checks include ensuring a 
project has a favourable (or pending) REC opinion, 
appropriate sponsorship and indemnity, as well as 
broadly reviewing potential risks that the project 
may pose to participants and staff. 
An NHS organisation is a legal entity 
responsible for its own local governance checks, 
therefore the application will be passed on from 
the central service to each local NHS R&D office at 
the sites in which it is proposed that the research 
is carried out. Local governance checks consider 
the aspects of the research study that are specific 
to each participating NHS research site. They 
establish whether there are suitable resources, 
equipment and facilities locally and make sure 
that appropriate arrangements are in place to 
allow the research to be undertaken. 
Locally, R&D departments need to be satisfied 
that it is feasible to carry out the research within 
their organisation and that the well-being of their 
patients is being promoted. 
The processes involved in applying for 
approvals
The processes involved in applying for approvals 
are summarised in Fig. 1 and are explained in 
detail in this section. Before applying for the 
necessary approvals, a research idea should be 
developed and the study carefully designed (see 
‘Study design’). Funding should have been agreed 
and a sponsor identified.
Sponsorship
Prior to obtaining REC and R&D permissions, 
a project needs to be approved by the research 
‘sponsor’. The sponsor is the institution or 
organisation responsible for the management 
and financing of the research (e.g. a health 
board/authority or an educational institution). 
The sponsor needs to approve all aspects of the 
proposed research before submission to the review 
bodies, including the protocol, information sheets 
and consent forms. They also provide indemnity 
for the research.
TABLE 1 Examples of review bodies whose permission may be required to carry out 
research
Research permission body Purpose
Research ethics committee (REC) To give an overall opinion on whether the 
proposed research is ethical 
Research and development (R&D) 
department
To support and promote the delivery of research 
in the National Health Service, particularly in 
the relevant health board/authority
Medicines and Healthcare products 
Regulatory Agency (MHRA)
Review of clinical trials of investigational 
medicinal products or medical devices
National Offender Management Service 
(NOMS) 
Review of projects involving prisons or 
probation trusts
Administration of Radioactive Substances 
Advisory Committee (ARSAC) 
Review of research involving administration of 
radioactive medicinal products
Human Fertilisation and Embryology 
Authority (HFEA) 
Review of research involving human embryos 
and gametes
Human Tissue Authority (HTA) Review of research involving storage of material 
from a human body
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Electronic submission process
Research permissions, including REC and 
R&D approvals, are then applied for in parallel 
through the Integrated Research Application 
System (IRAS, www.myresearchproject.org.uk), 
a single online portal for health and social care/
community care research in the UK. IRAS enables 
information about the project to be entered just 
once for all review bodies, including both REC and 
R&D, using filters to ensure that the data collected 
are appropriate to the type of study and the bodies 
being applied to. All documents, including the 
protocol, information sheets, consent forms, and 
evidence of sponsorship, funding and peer review 
are submitted to the review bodies electronically 
via the IRAS website. A representative of the 
sponsor, in addition to the chief investigator, needs 
to approve the whole submission electronically 
via IRAS.
RECs
Researchers will usually apply to their local REC. 
Some REC panels will have specific interests 
and expertise (e.g. in reviewing clinical trials 
of medicinal products), and researchers should 
check which panel would be the most suitable to 
review their study. Researchers submitting a full 
application to a REC are invited to attend the 
committee meeting(s) at which a decision is made 
about the suitability of their proposed research. It 
is in the best interests of the research team for at 
least one representative to attend these meetings to 
FIG 1 The research approval process. IRAS, Integrated Research Application System; NHS, National Health Service; R&D, 
research and development; REC, research ethics committee.
Develop research idea, agree funding and obtain sponsor approval
Complete IRAS form and ensure all study documents are complete 
(information sheets, consent forms)
R&D
Approvals from other bodies may be required
REC
Obtain electronic authorisations on IRAS form  
(from sponsor and chief investigator)
Submit application to central coordinating unit or 
local R&D
Application validated by R&D
Global governance review conducted centrally
Local governance review conducted by NHS 
organisation
Governance report generated
Make any amendments requested by R&D
Obtain electronic authorisations on IRAS form  
(from sponsor and chief investigator)
Book place with a REC and submit application to 
REC
Application validated by REC
Application reviewed by REC. Further information 
may be requested
Decision made
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provide any clarifications needed. The researcher 
must satisfy the REC that their research will be 
ethical and worthwhile, and that any risks to 
participants are minimised and justified. The REC 
may approve the proposed research immediately, 
but will probably require amendments which will 
need to be resubmitted, either for further scrutiny 
by the committee if major or for approval by the 
committee’s chair if minor. Once approved, a 
formal letter is issued in confirmation.
R&D
Once the R&D application is made via IRAS, the 
central body then passes it on to the local R&D 
department involved for approval of the details of 
the research. If the proposed study involves more 
than one site (e.g. a number of hospitals/clinics), 
with protocol differences at each, a Site Specific 
Information form (via IRAS) will be needed for 
each site to explain these differences. However, 
there will normally be a lead NHS R&D office for 
the project (usually the NHS organisation that 
employs the chief investigator of the study). If 
applying to more than one R&D department, each 
office may require their own amendments to be 
made. These may be different to each other and to 
those required by the REC. Any changes required 
by the R&D departments should be notified to 
the REC and vice versa. Once approved, an NHS 
permissions letter must be provided by each NHS 
organisation before the research is started. This 
R&D approval is required prior to starting the 
research, even if a favourable ethical opinion has 
already been obtained. 
In addition to obtaining R&D approvals 
for the research, it is necessary to clarify the 
organisation of local governance procedures 
to identify which further paperwork needs to 
be completed in relation to the project. For 
example, a Disclosure and Barring Service (DBS) 
(formerly Criminal Records Bureau, CRB) check 
is likely to be required if the research is being 
carried out at an organisation which is not the 
researcher’s employing organisation and there are 
inconsistencies as to which trusts/health boards 
accept the research passport. It would be useful to 
clarify these procedures early on in the process to 
avoid delays in starting the research.
R&D departments have a target to ensure that 
the first participant is recruited into a study within 
a set time after approvals have been granted. The 
duration of this interval is currently changing from 
60 days to 30 days, with some offices aiming for 
15 days. It is therefore important that researchers 
do not gain approvals before they are able to start 
recruiting or they may miss this target.
Considerations when planning mental 
health research
There are a multitude of ethical and other issues 
which need to be considered when carrying out all 
research, including mental health research. This 
section does not aim to be exhaustive; rather, it 
gives an overview of the main issues involved at 
each stage of the research process that may be 
relevant to approval bodies. Case studies from our 
own experiences in child and adolescent mental 
health research (Boxes 1–3) illustrate various 
issues that we have encountered in different 
research areas. 
Study design
As with all other health research, a study should be 
designed appropriately so that it is able to answer 
the research question and test the postulated 
hypotheses; equally, any data gathered should be 
pertinent to the study question. This will ensure 
the best use of resources and participants’ time. 
Both the research sponsor and the REC are 
likely to require evidence that a proposal has 
been externally peer reviewed, and this will help 
ensure that a study is well designed prior to the 
approval process. 
Depending on the question being posed, recruit-
ment of a control group is often an important 
aspect of study design. This raises the issue of 
BOX 1 Developing and evaluating an online 
mental health intervention for young 
people
E-mental health (the use of digital technologies to help 
with mental health issues and difficulties) is a growing 
area of research. One of the authors is involved in the 
development and evaluation of an online package to help 
prevent and manage mental health difficulties in young 
people. Some of the considerations for the design of this 
project included how best to consult potential users of 
the package during its development and evaluation, and 
interviews and focus groups with young people, parents/
carers and professionals were arranged. It was important 
to facilitate engaging, non-judgemental and friendly 
discussions without disclosing personal experiences or 
psychiatric histories of vulnerable participants, especially 
in the young person focus groups. Other considerations 
included the use of non-stigmatising, age-appropriate 
language for the package and project documents 
(information sheets, consent forms), so that individuals 
were not identified according to their mental health 
difficulties. The intervention will include mood-monitoring 
components and links to social media and forums, and 
a secure database and regulated site is paramount, 
ensuring users are not identified or cyberbullied. 
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who are suitable controls? Controls should be as 
similar to cases as possible and this may involve, 
for example, matching on characteristics such as 
age, gender or IQ. However, in certain instances, 
when a variable on which matching is proposed is 
associated with case status, matching may remove 
the variance associated with the characteristic 
under study so this needs to be carefully considered. 
Individuals volunteering as controls for scientific 
studies are likely to be highly motivated, but may 
have particular reasons for taking part, such as 
an affected family member, which could act as 
a genetic confound for heritable disorders. Such 
issues need careful attention and the decision on 
who to recruit as controls will depend both on the 
research questions posed and pragmatism with 
regard to what is achievable.
Consultation at each stage of research
It is recommended that a range of individuals 
and groups are consulted when planning each 
stage of the research. In fact, consultation is an 
expectation of the ethical review process. Potential 
consultants could include patient groups as well 
as individuals, families, carers, professionals 
and charities who are associated with the area of 
interest. Consultations could range from informal 
communication and meetings, to the use of 
questionnaires, semi-structured interviews and 
BOX 3 Longitudinal clinical research in ado-
lescents with developmental disorders
Understanding the clinical course of neurodevelopmental 
disorders is important in order to be able to make 
predictions about an individual’s prognosis and identify 
potentially modifiable factors which may improve 
outcomes. One of the authors is involved in a study 
using questionnaire and structured interview-based 
assessments of adolescents with attention-deficit 
hyperactivity disorder (ADHD) to examine the relationship 
between childhood ADHD and later depression. 
Development of information leaflets for different age 
groups has been an important aspect of this project. It 
has been imperative to be clear that a research interview 
is not a clinical contact and may not provide any direct 
benefit to participants. As young people are undertaking 
research diagnostic interviews and answering detailed 
questions on their emotions and behaviours, it has been 
important to have a clear protocol in place to deal with 
distress, worrying disclosures, or disclosure of significant 
symptoms of mental illness during an interview. In 
view of the likelihood of these occurrences during 
interviews with a clinical population, an explanation of 
confidentiality has been particularly relevant.
BOX 2 Neuroimaging in adolescents with 
neurodevelopmental disorders
Rapid advances in technology mean that the utility of 
magnetic resonance imaging (MRI) in mental health 
research has increased greatly over the past few years. 
Two of the authors are involved in studies investigating 
the aetiology of neurodevelopmental disorders using 
structural and functional MRI scanning in adolescents. 
Considerations pertinent to these projects have 
included the development of group- and age-specific 
information sheets (including those for younger and 
older adolescents), the length the sheets had to be 
to include all the information about the scanning 
procedure, and the delivery of this complex information 
in appropriate language. One of the projects has also 
included participants with intellectual disabilities, 
necessitating particular consideration of the issue of 
capacity to consent. Careful thought has been given 
to the acceptability of the scanning process to young 
people by age-appropriate explanations and the use of 
a ‘mock’ scanner first to acclimatise participants to the 
scanning environment. Both studies have formed part 
of larger longitudinal studies and the effort involved for 
individuals to participate repeatedly has been gratefully 
acknowledged by the researchers.
focus groups. Themes to discuss could include the 
method of recruitment, the design of information 
sheets and the acceptability of the study protocol 
– particularly in view of the potential difficulties in 
identifying and engaging participants (e.g. due to 
the symptoms and stigma associated with mental 
illness, as will be described below). 
In the UK there is a strong tradition of encour-
aging service user involvement in the planning 
and undertaking of mental health research. This 
approach has been shown to benefit both the 
service users and researchers (see NHS National 
Institute for Health Research’s (2013) guidance on 
involving people with experience of mental health 
problems in research).
Recruitment methods
Recruitment methods need careful thought. 
There are many possible avenues for recruitment, 
but broadly these would fall under (a) direct 
identification of potential participants through 
previous studies, population studies, clinics and 
charities, and (b) study adverts (e.g. websites, 
posters, newspapers), depending on the group 
being targeted. 
Once potential participants have either been 
identified or have volunteered, there are several 
methods of communicating with them about a 
study. This could involve individuals and families 
being invited directly, for example when they attend 
BJPsych Advances (2016), vol. 22, 64–72 doi: 10.1192/apt.bp.114.014035 69
Approvals for mental health research
a clinic, or having a letter sent out by the local 
study lead. Over recent years, however, electronic 
methods of communicating such as email or SMS/
text messaging have been used increasingly. 
There are particular issues and risks pertinent 
to all modes of invitation, for example that an 
invitation will be received by someone other than 
the person targeted. The postal address, email 
or telephone number of the individual should 
be confirmed before the communication is sent 
out. If possible, invitation documents should not 
suggest that the person is being invited because 
of a particular diagnosis or difficulty – this is 
especially important in relation to the sensitivity 
of psychiatric diagnoses. 
Challenges in engaging potential participants
Participant recruitment can pose a major 
challenge in mental health research. In studies 
where potential participants are recruited from 
clinics, medical staff may express their support to 
help with recruitment but may not actually have 
the time to be able to do so in the context of a busy 
clinic setting. Close liaison with clinicians about 
the nature of the project and having project staff sit 
in on clinics to help with recruitment can facilitate 
clinicians’ involvement in the process. Also, 
although in our experience people with psychiatric 
disorders tend to be broadly supportive of being 
involved in research, the nature of psychiatric 
symptoms may affect an individual’s interest 
in and their ability to participate. For example, 
patients with depression may not feel motivated 
to take part during episodes of low mood, patients 
with psychosis may lack insight into how their 
condition affects their ability to engage, and 
those with attention-deficit hyperactivity disorder 
may lack the organisational skills to liaise with 
researchers about participating. This may result 
in inherent biases in recruited patient samples, 
with those with less severe symptoms, higher IQ 
and socioeconomic status, and those in remission 
being more likely to participate. Furthermore, for 
vulnerable groups such as children and adults 
lacking capacity participation is likely to also 
involve a carer. Therefore the decision about 
whether or not to participate will be influenced 
by their carers’ ideas, concerns and expectations 
about research, and indeed their psychopathology. 
Confidentiality and data protection
Although many people with mental health problems 
are enthusiastic about research, mental health 
problems continue to be associated with stigma 
(Corrigan 2005), which may prevent patients from 
wanting to be recruited into research. There may 
be instances where an individual would wish to 
conceal their diagnosis from their doctor, employer 
and family members. Ensuring confidentiality 
about mental health problems is paramount when 
undertaking research in this area. 
The collection and storage of study data must 
be operationalised such that participants are not 
identifiable to those outside the research team, and 
researchers must adhere to the Data Protection 
Act 1998 in how they record, anonymise/
pseudoanonymise and securely store the data, and 
must specify in the approval documents how this 
adherence will be achieved. However, there may be 
times when confidentiality needs to be breached, 
for example if a patient makes a clinically 
significant, risky disclosure during the course of 
a study. Clear procedures must be in place to deal 
with such instances.
Reasons for participating
Potential participants should be made aware of 
opportunities to take part in research without 
feeling pressurised or coerced. The possible 
advantages and disadvantages of participating 
must be clear from the outset. It must be made 
explicit that individuals are free to take part and 
withdraw from the study without any negative 
impact on their clinical care. 
As is the case for research in all medical 
specialties, mental health research relies heavily 
on the goodwill of participants, as studies (e.g. 
epidemiological, genetic and neuroimaging studies, 
and even trials) may not provide them with any 
direct, tangible or immediate benefit. In such 
instances, it must be made clear that participating 
in the study is only to help better understand 
the aetiology of a disorder or the mechanism of 
an intervention, and to help others who might 
be affected in the future. Gift vouchers are often 
used (especially for young people as a substitute 
for cash payments) as a reward or recognition for 
involvement in research (Mental Health Research 
Network 2013), and this should be made clear to 
ensure that a legitimate reward does not act as an 
incentive in itself. 
Capacity and consent
An individual’s capacity to consent to participate in 
research is distinct from their capacity to consent 
to treatment. The HRA’s guidance on the Mental 
Capacity Act 2005 states that ‘a core principle 
of the Act is that capacity should be assumed 
unless established otherwise. If a participant has 
consented to take part, it may generally be assumed 
that capacity remains in place but the researcher 
should be alert to any changes suggesting that 
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capacity has been lost’ (NHS Health Research 
Authority 2013). However, gaining informed 
consent to participate in research may be difficult 
in some patient groups. For some disorders, an 
individual’s capacity to consent to participate 
may be persistently affected or may fluctuate (e.g. 
intellectual disabilities, schizophrenia, dementia). 
It is therefore imperative that all members of the 
research team have adequate training in this area. 
Different information sheets (see below) may be 
needed so that material is clear and understandable 
to participants of different ages and with different 
levels of cognitive functioning, to allow them to 
provide properly informed consent. Participants 
must be given sufficient time (usually at least 
48 h) to read the information sheets, digest their 
contents and obtain any answers to questions 
they might have before agreeing to take part. 
Children under 16 years old are not allowed to 
provide consent to take part in research and so 
will need to sign an ‘assent’ form in tandem with 
a parental consent form. It is also good practice 
to obtain parental consent for those aged 16–18 
years old to participate in research. Consent forms 
need to be designed so that consent to each facet of 
the research process is signed for separately, such 
that a participant could agree to some parts of the 
research but not others.
Information sheets 
Both the content and design of the information 
sheet are important in determining whether it 
is effective in engaging and informing potential 
participants and their families and carers. The 
language needs to be targeted to a lay audience, 
with the avoidance of stigmatising language and 
medical jargon. For example, it is preferable to 
describe someone as an individual with a particular 
disorder, such as ‘a person with schizophrenia’ 
rather than as ‘a schizophrenic’. It is particularly 
important to consider the age group under study, 
and it is best practice for leaflets for children to 
be presented differently according to whether they 
are under 16 years old or 16–18 years old (National 
Patient Safety Agency, National Research Ethics 
Service 2011).
The choice of overall visual design and imagery 
can affect the way in which an information sheet 
is read, and an unhelpful image next to the 
text can detract from the message. There is a 
tradition of overusing certain imagery in relation 
to mental health, especially negative ones, for 
example photographs of people in the ‘fetal’ 
position holding their head in the corner of a 
room. Organisations such as the Samaritans have 
published guidelines regarding reporting and the 
use of images, particularly in relation to suicide 
(Samaritans 2013). Time to Change also launched 
the Get the Picture campaign in 2015, with a wide 
range of images suitable to be published in relation 
to mental health issues (www.time-to-change.org.
uk/getthepicture).
A balance needs to be struck between making 
information sheets short enough to be accessible, 
especially for children, and including all the 
necessary detail about the research process. This 
can be difficult to achieve.
Newsletters and feedback 
It is good practice to provide feedback to research 
participants on the progress and outcomes of the 
study, which could be in the form of newsletters, 
presentations or meetings. This is particularly 
important because mental health research often 
provides no contemporaneous direct benefit to 
participants as previously discussed. Feedback not 
only helps inform those involved of the results of 
their important contribution, but could help make 
them feel engaged in the process and increase 
the likelihood of them wishing to participate in 
future studies. 
General advice and considerations for the 
future
Consulting REC and R&D guidelines and 
departments 
It is advisable to consult electronic resources as well 
as relevant individuals and organisations in the 
initial stages of planning mental health research. 
This will help in adhering to guidelines as closely 
as possible and avoiding unnecessary delays in 
the review process, which may affect the project 
start date. There are freely available guidelines 
for various aspects of commencing a new research 
project (e.g. for designing information sheets and 
consent forms: www.hra.nhs.uk/resources/before-
you-apply), which are updated regularly. Although 
parallel applications for all R&D departments 
are recommended, it is advisable to engage in 
discussion with the R&D department most closely 
affiliated with your centre and the REC office at 
the initial stages of writing the research plan. This 
can help pre-empt difficulties and challenges, save 
time and paperwork, and build good working 
relationships with individuals who can help 
facilitate current and future research projects. 
Streamlining and centralisation
In a multicentre study, the process of completing 
the initial documentation, responding to each 
department’s queries and making the necessary 
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amendments can be time consuming. Therefore, 
it is important to factor in the time required 
accordingly. However, plans are afoot to further 
stream line the governance processes – there will 
be changes, for example, to the approvals system 
in Wales in line with those proposed by the HRA 
in England (Health and Care Research Wales 
2015). This is a positive development as it will 
potentially avoid duplication and will expedite 
the review process, without affecting its rigour 
or standards.
Online and other electronic approaches
Over recent years, the process of applying for 
REC or R&D reviews has become increasingly 
reliant on electronic means, with all documents 
now submitted online via the IRAS. It is likely 
that it will become more ‘electronic’ in future, 
with greater emphasis on user interface design 
and streamlining the process. Other aspects are 
also likely to become more electronic, for example 
research participant recruitment, information 
sheets and consent forms, mental health research 
assessments and recording of responses to 
interventions. This will require more dialogue 
with local information services and consideration 
of the benefits (e.g. time saving, ease of access 
to information, ease of participant response) as 
well as risks (e.g. storage failure, safe storage of 
and access to identifiable data, confidentiality) 
of using digital technologies. These issues are 
also pertinent to the growing area of e-mental 
health (Box 1), including the development and 
evaluation of electronic clinical assessment tools 
and interventions. 
Collaborations with other groups in academia 
and other sectors
Research teams are becoming increasingly multi-
disciplinary (e.g. health and education, laboratory 
and clinical teams). There are also collaborations 
between public, private and third-sector 
organisations. In additional, multicentre research 
projects – which seek to analyse large quantities 
of data to improve the power of studies – involve 
collaborative efforts between various research and 
clinical centres at local, national and international 
levels. Researchers should have an appreciation of 
the ethical, legal and research processes of each 
participating discipline, organisation and country. 
They should ensure that they understand their site-
specific responsibilities and allow sufficient time 
for approvals to be gained locally. Given that there 
will be shared, but also possibly varying interests 
across involved parties, it is important to be aware 
of any competing interests from the outset. 
Greater consultation with potential research 
participants 
As described previously, there is an expectation 
that potential research participants are consulted 
from an early stage with regard to the research 
plan. This is likely to become more formalised 
over coming years, with groups set up with 
interests in different aspects of mental health (e.g. 
parents of children with mental health disorders). 
Such groups might also approach researchers 
with ideas and plans for projects of their own. 
Public engagement training is important in this 
regard. Evidence of consultation with potential 
participants is especially helpful to inform the 
acceptability of research protocols, as there is 
evidence that RECs can overestimate the distress 
that they think research will cause participants 
(Petrie 2013).
Conclusions
Research permissions have become an integral 
part of research preparation in all areas of 
medicine. However, individuals with mental 
health difficulties are a vulnerable population, and 
aspects that need special consideration include 
recruitment methods, stigma and confidentiality, 
and capacity and consent. Feedback obtained from 
both RECs and R&D departments provides a useful 
external perspective and can highlight ethical 
and organisational issues which may not have 
been considered. It is important to make contact 
with the relevant REC and R&D department 
early in the development of a research proposal. 
Although their roles may seem duplicative, they 
are in fact quite different, with RECs providing 
an independent opinion on ethical aspects of 
the proposed research, and R&D departments 
considering issues pertinent to the environment 
in which the research is going to be carried out 
and the risks which the NHS organisations might 
incur in hosting the research. It is important to 
consider that even with a favourable decision on 
the project’s ethics, research cannot commence 
unless the R&D department is satisfied that all 
issues that have been raised have been addressed 
satisfactorily. 
The process of filling out the required 
paperwork can be very time consuming and thus 
it is essential to be familiar at the outset which 
forms need to be completed and which agencies 
need to be involved at each stage of the application, 
and factor in time accordingly. In future, it would 
be ideal if the processes involved could become 
more streamlined, while ensuring there is no 
compromise to the integrity of the review process 
and thus to participant and researcher safety. 
MCQ answers
1 b 2 d 3 b 4 d 5 a
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MCQs
Select the single best option for each question stem
1 All research involving NHS patients 
requires the approval of which regulatory 
body?
a Medicines and Healthcare products Regulatory 
Agency (MHRA) 
b Research ethics committee (REC)
c Research and development (R&D) department
d Human Tissue Authority (HTA)
e Human Fertilisation and Embryology Authority 
(HFEA) .
2 Who provides indemnity for research 
activity?
a the chief investigator 
b the REC
c the R&D department
d the research sponsor
e the research funder.
3 What is the Integrated Research 
Application System (IRAS)?
a the body which provides approvals for research
b the system by which applications for REC and 
R&D approvals are made
c the body which reviews clinical trials of 
investigational medicinal products
d the system through which research funding is 
applied for
e the body which reviews research involving 
storage of material from a human body.
4 On average, within how many days does a 






5 The HRA manages the research ethics 
service of which country or region?
a England 
b Northern Ireland 
c Scotland 
d Wales
e the UK as a whole.
ADBB Structured, scored interpretation of clinician attempts to 
interact with children aged 2–24 months
Clinical cut-off has been replicated internationally; has 2 dimensions (temperamental 
and interpersonal) and is predictive of relationship and behavioural problems at 3 and 5 
years respectively
a. The M-CHAT was preferred to the Social Communication Questionnaire (SCQ) as there was evidence that the latter works less well in younger age ranges, requiring cut-off adjustment (Wiggins 2007).
3Di, Developmental, Dimensional and Diagnostic Interview; ADBB, Alarm Distress Baby scale; ADI-R, Autism Diagnostic Interview – Revised; ADOS, Autism Diagnostic Observation Schedule; 
ASEBA, Achenbach System of Empirically Based Assessment; Attachment Q-Sort; CHAT/M-CHAT, (Modified) Checklist for Autism in Toddlers; DAWBA, Development and Well-Being Assessment; 
DISCO, Diagnostic Interview for Social and Communication Disorders; ECI-4, Early Childhood Inventory for DSM-IV diagnoses; K-SADS-PL, Schedule for Affective Disorders and Schizophrenia for 
school-age children (Kiddie-), Present and Lifetime; NBAS, Neonatal Behavioral Assessment Scale; PAPA, Preschool Age Psychiatric Assessment; PAS-R, Preschool Anxiety Scale – Revised; PFC, 
Preschool Feelings Checklist; SDQ, Strengths and Difficulties Questionnaire.
CORRECTIONCorrection
Foreman D (2015) The psychiatry of children aged 0–4: advances in 
assessment, diagnosis and treatment. BJPsych Advances, 21: 377–86.
The last row and footnote of Table 2, on p. 380, 
should read:
doi: 10.1192/apt.22.1.72
